The DNA G-quadruplex
is known for forming a range of topologies
and for the observed lability of the assembly, consistent with its
transient formation in live cells. The stabilization of a particular
topology by a small molecule is of great importance for therapeutic
applications. Here, we show that the ruthenium complex Λ-[Ru(phen)2(qdppz)]2+ displays enantiospecific G-quadruplex
binding. It crystallized in 1:1 stoichiometry with a modified human
telomeric G-quadruplex sequence, GGGTTAGGGTTAGGGTTTGGG (htel21T18), in an antiparallel chair topology, the first structurally
characterized example of ligand binding to this topology. The lambda
complex is bound in an intercalation cavity created by a terminal
G-quartet and the central narrow lateral loop formed by T10–T11–A12. The two remaining wide
lateral loops are linked through a third K+ ion at the
other end of the G-quartet stack, which also coordinates three thymine
residues. In a comparative ligand-binding study, we showed, using
a Klenow fragment assay, that this complex is the strongest observed
inhibitor of replication, both using the native human telomeric sequence
and the modified sequence used in this work.